Dr. Thomas Lehman, manager of method development and validation, published “Lancaster Labs develops extractables database for LC/MS analysis” in Pharmaceutical Technology, on-line in May 2009.
Mike Yunginger, manager of non-sterile products and organism identification, published“Harmonized Microbial Limits Methods” in Contract Pharma, March 2009.
Dr. Timothy Oostdyk, executive vice president and COO, contributed to the CRO Roundtable in Life Science Leader, March 2009. The article is titled, “The Future Of The CRO-Pharma Relationships.”
Dr. Shankaramma Shivaprasad, principal scientist, Biopharmaceutical Services;
Dr. Robert J. Duff, manager, Biopharmaceutical Services; Dr. Jon S. Kauffman, director, Biopharmaceutical Services and Analytical Method Development/Validation authored “Protein Sequencing Using High Resolution LC-MS/MS” for WCBP 2009.
Dr. Robert J. Duff, manager, Biopharmaceutical Services, and Dr. Jon S. Kauffman, director, Biopharmaceutical Services and Analytical Method Development/Validation Characterization, authored “Synthetic Oligonucleotides by High Resolution LTQ-Orbitrap Mass Spectrometry: Method Development and Qualification” for WCBP 2009.
Dr. Robert J. Duff, manager, Biopharmaceutical Services, and Dr. Shankaramma Shivaprasad, principal scientist, Biopharmaceutical Services presented “Characterization of an Oligonucleotide-Derived Conjugate by High Resolution Mass Spectrometry: Method Development and Qualification using LTQ-Orbitrap” at TIDES.
Research advisors Dr. Neeraj Chopra (Lancaster Labs), Dr. David Hollowell (Eli Lilly) and Jeff Vincenzi (Eli Lilly) presented “Analysis of MOE Phosphoramidite Impurities” at TIDES.
Look for Lancaster Labs’ cover article on Cleaning Validation in Pharmaceutical Formulation & Quality’s Outsourcing Guide in the June/July issue.